IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sectoral Asset Management Inc

Q1 2018 Holdings

Filed 2018-05-15 | 68 holdings | $84.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Unitedhealth GRP Inc(UNH)COMMON91324P102$19.7K92,2030.0%
Abiomed Inc(ABMDEUR)COMMON003654100$22.4K76,8170.0%
K2m Group HoldingsCOMMON48273J107$23.1K1,221,1600.0%
Exact Sciences Corp(EXAS)COMMON30063P105$23.2K574,0490.0%
Sarepta Therapeutics(SRPT)COMMON803607100$24.3K327,6980.0%
Teladoc Inc(TDOC)COMMON87918A105$26.1K646,8280.0%
Celgene Corp(CELG)COMMON151020104$27.3K306,1300.0%
Johnson & Johnson(JNJ)COMMON478160104$28.3K220,9480.0%
Pfizer Inc(PFE)COMMON717081103$28.5K804,2740.0%
Novartis AG(NVSN)SP ADR66987V109$28.7K355,2960.0%
Aerie Pharmaceuticals(AERIEUR)COMMON00771V108$29.2K538,6180.0%
LA Jolla Pharmaceutical(LJPC)COMMON503459604$33.6K1,128,2190.0%
Apellis Pharmaceutic(APLS)COMMON03753U106$36.4K1,647,6920.0%
Amicus Therapeutics(FOLD)COMMON03152W109$51.2K3,405,5410.1%
Accuray Inc(ARAY)COMMON004397105$1.9M384,5472.3%
Acadia Pharmaceuticals(ACAD)COMMON004225108$17.6M783,42420.9%
Collegium Pharmaceutical(COLL)COMMON19459J104$31.6M1,236,53437.5%
Biomarin Pharmac Inc(BMRN)COMMON09061G101$32.3M397,90338.3%
PreviousPage 2 of 2